Brenus Pharma

Description

Brenus Pharma is a French clinical-stage biotech developing a pioneering technology platform, Stimulated-Tumor-Cell (STC). STC is designed to generate 'off-the-shelf' , first-in-class therapeutic cancer vaccine leading the way to a new precision medicine in immuno-oncology. Brenus Pharma is on the brink of a breakthrough and will start its First in Human study in 2024 in colorectal cancer, 2nd cause of cancer-related deaths worldwide. We are building a strong portfolio in solid tumors, leveraging our patented STC platform, to change a paradigm in oncology.

HealthTech Innovation Days - 6th edition is an event organized by HealthTech For Care.

HealthTech For Care is an endowment fund (non-for profit organization) whose primary mission is to advocate for universal access to healthcare for all European patients, with a specific focus on advanced medical technologies and innovative drugs. The fund's initiatives and events with a European dimension gather all stakeholders involved in the health innovation value chain, fostering better coordination within the European health ecosystem. HealthTech For Care is administered by a board of European experts.

For any request: contact@htfc-eu.com
Where to find us? Healthtech For Care, 10 Place de Catalogne, 75014 Paris

Brenus Pharma

Description

© HealthTech For Care 2022-2024 - All rights reserved

Cookies Policy

Legal notice

Privacy Policy